HSP90 inhibition: two-pronged exploitation of cancer dependencies

23 January 2012
Download Type: Adobe PDF

In this article Jon Travers, Swee Sharp and Paul Workman evaluate the key role of HSP 90 in enabling the functional and structural stabilisation of a host of client oncoproteins.

Furthermore, the authors they identify routes to improve the clinical efficacy of HSP90 inhibitors, based on emerging knowledge.